Literature DB >> 10221491

Graft function 5-7 years after renal transplantation in early childhood.

E Qvist1, J Laine, K Rönnholm, H Jalanko, M Leijala, C Holmberg.   

Abstract

BACKGROUND: Low recipient age is still a risk factor for graft failure after kidney transplantation (Tx). Detailed prospective reports on long-term graft function in small children after renal Tx are still lacking.
METHODS: Forty-nine kidney allograft recipients who received transplants before the age of 5 years were followed prospectively. The most common disease was congenital nephrotic syndrome of the Finnish type. Twenty patients were recipients of living related donors (LRD), and 29 were cadaveric kidney (CAD) recipients. All patients received triple immunosuppression. Glomerular filtration rate (GFR), effective renal plasma flow (ERPF), sodium, urate, and potassium handling, and concentrating capacity were studied for up to 7 years after Tx.
RESULTS: Patient survival 7 years after Tx was 100% for LRD and 96% for CAD recipients. Graft survival was 94% for LRD and 79% for CAD recipients (P=NS) and 89% and 83% for children >2 years and <2 years of age at Tx, respectively (P=NS). Five years after Tx, GFR was 70 vs. 64 and ERPF was 380 vs. 310 ml/min/1.73 m2 for LRD and CAD recipients, respectively (P=NS). Mean absolute GFR remained stable. GFR was lower in children who received transplants at <2 years than in children who received transplants at >2 years of age, 54 vs. 75 ml/min/1.73 m2 (P=0.02). Sodium handling remained intact, but hyperuricemia was seen in 43-67%; 17-33% showed abnormal handling of potassium; and most patients had a subnormal concentrating capacity.
CONCLUSIONS: Excellent long-term graft survival and good graft function can be achieved with triple immunosuppression, even in young CAD kidney recipients.

Entities:  

Mesh:

Year:  1999        PMID: 10221491     DOI: 10.1097/00007890-199904150-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Cyclosporine A monitoring--how to account for twice and three times daily dosing.

Authors:  Samuel Fanta; Janne T Backman; Paula Seikku; Christer Holmberg; Kalle Hoppu
Journal:  Pediatr Nephrol       Date:  2005-03-17       Impact factor: 3.714

Review 2.  Congenital nephrotic syndrome.

Authors:  Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2007-10-30       Impact factor: 3.714

3.  Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome.

Authors:  Saskia F Heeringa; Christopher N Vlangos; Gil Chernin; Bernward Hinkes; Rasheed Gbadegesin; Jinhong Liu; Bethan E Hoskins; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2008-05-23       Impact factor: 5.992

4.  25 years of live related renal transplantation in children: The Buenos Aires experience.

Authors:  Eduardo Ruiz; Jorge Ferraris
Journal:  Indian J Urol       Date:  2007-10

5.  Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS).

Authors:  Dominik S Schoeb; Gil Chernin; Saskia F Heeringa; Verena Matejas; Susanne Held; Virginia Vega-Warner; Detlef Bockenhauer; Christopher N Vlangos; Khemchand N Moorani; Thomas J Neuhaus; Jameela A Kari; James MacDonald; Pawaree Saisawat; Shazia Ashraf; Bugsu Ovunc; Martin Zenker; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2010-02-18       Impact factor: 5.992

Review 6.  Pathology of Podocytopathies Causing Nephrotic Syndrome in Children.

Authors:  Sarangarajan Ranganathan
Journal:  Front Pediatr       Date:  2016-03-31       Impact factor: 3.418

Review 7.  Congenital nephrotic syndrome: is early aggressive treatment needed? Yes.

Authors:  Tuula Hölttä; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2020-05-06       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.